Challenges and Advances in Pharmacology, Antibiotics, and Drugs Vol. 1

Dr. Tanya Berg, (Editor)

This book covers keys areas of Pharmacology. The contributions by the authors include Allergology, Alternative medicine, Andrology, Anesthesiology, Angiology, Audiology, Autoimmunity, Biochemistry, Bioethics, Bioinformatics, Cardiac surgery, Cardiology, Cell biology, Dentistry, Dermatology, Diabetes, Dietary supplementation, Editorial, Emergency Medicine, Endocrinology, Epidemiology, Food supplementation, Forensic Medicine, Gastroenterology

Chapters of the book:

Chapter 1: Nucleoside analog GS‐441524: pharmacokinetics in different species, safety, and potential effectiveness against Covid‐19
Henrik Berg Rasmussen, Ragnar Thomsen, Peter Riis Hansen
Challenges and Advances in Pharmacology, Antibiotics, and Drugs Vol. 1, 26 January 2022, Pages: 5-23

Chapter 2: The effects of apixaban on clot characteristics in atrial fibrillation: A novel pharmacodynamic biomarker
Matthew J. Lawrence, Vanessa Evans, Janet Whitley, Suresh Pillai, Phylip R. Williams, James Coulson, Manju Krishnan, Peter Slade, Kieron Power, Roger H.K. Morris, Phillip A. Evans
Challenges and Advances in Pharmacology, Antibiotics, and Drugs Vol. 1, 26 January 2022, Pages: 24-40

Chapter 3: Evaluation of in vitro transdermal permeation, mass spectrometric imaging, and in vivo analgesic effects of pregabalin using a pluronic lecithin organogel formulation in mice
Michiru Nagao, Masataka Tajima, Erika Sugiyama, Ryosuke Shinouchi, Keita Shibata
Challenges and Advances in Pharmacology, Antibiotics, and Drugs Vol. 1, 26 January 2022, Pages: 41-65

Chapter 4: A physiologically based pharmacokinetic model of clopidogrel in populations of European and Japanese ancestry: An evaluation of CYP2C19 activity
Janna K. Duong, Romina A. Nand, Aarti Patel, Oscar Della Pasqua, Annette S. Gross
Challenges and Advances in Pharmacology, Antibiotics, and Drugs Vol. 1, 26 January 2022, Pages: 66-88

Chapter 5: Dexamethasone promotes breast cancer stem cells in obese and not lean mice
Stephanie Annett, Orla Willis Fox, Damir Vareslija, Tracy Robson
Challenges and Advances in Pharmacology, Antibiotics, and Drugs Vol. 1, 26 January 2022, Pages: 89-114

Chapter 6: CRISPR/Cas9 unveils the dynamics of the endogenous µ‐opioid receptors on neuronal cells under continuous opioid stimulation
Satoshi Shimizu, Atsuko Shiraki
Challenges and Advances in Pharmacology, Antibiotics, and Drugs Vol. 1, 26 January 2022, Pages: 115-126

Chapter 7: Community pharmacists workforce readiness to deliver vaccination services: A cross‐sectional study from Jordan
Saja A. Alnahar, Georgios Gkountouras, Rula M. Darwish, Ian Bates
Challenges and Advances in Pharmacology, Antibiotics, and Drugs Vol. 1, 26 January 2022, Pages: 127-146

Chapter 8: Nonsteroidal anti-inflammatory drugs in acute viral respiratory tract infections: An updated systematic review
Nima Azh, Farzaneh Barzkar, Nogol Motamed-Gorji, Parmida Pourvali-Talatappeh, Yousef Moradi, Roya Vesal Azad, Mitra Ranjbar, Hamid Reza Baradaran
Challenges and Advances in Pharmacology, Antibiotics, and Drugs Vol. 1, 26 January 2022, Pages: 147-166

Chapter 9: Drug repurposing strategies of relevance for Parkinson’s disease
Edward J. R. Fletcher, Thomas Kaminski, Gareth Williams, Susan Duty
Challenges and Advances in Pharmacology, Antibiotics, and Drugs Vol. 1, 26 January 2022, Pages: 167-180

Chapter 10: Pharmacological hypotheses: Is acetaminophen selective in its cyclooxygenase inhibition?
Christopher J. Esh, Bryna C. R. Chrismas, Alexis R. Mauger, Lee Taylor
Challenges and Advances in Pharmacology, Antibiotics, and Drugs Vol. 1, 26 January 2022, Pages: 181-200

Chapter 11: Ocular safety of repeated intravitreal injections of Carboplatin and Digoxin: A preclinical study on the healthy rabbits
Alireza Khodabande, Fariba Ghassemi, Fahimeh Asadi Amoli, Hamid Riazi-Esfahani, Raziyeh Mahmoudzadeh, Mohammad Mehrpour, Niloufar Valipour
Challenges and Advances in Pharmacology, Antibiotics, and Drugs Vol. 1, 26 January 2022, Pages: 201-211

Chapter 12: Alignment between outcomes and minimal clinically important differences in the Dutch type 2 diabetes mellitus guideline and healthcare professionals’ preferences
Marloes Dankers, Marjorie H. J. M. G. Nelissen-Vrancken, Bertien H. Hart, Anke C. Lambooij, Liset van Dijk, Aukje K. Mantel-Teeuwisse
Challenges and Advances in Pharmacology, Antibiotics, and Drugs Vol. 1, 26 January 2022, Pages: 212-224